Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric carboxymaltose vs placebo in chronic heart failure with iron deficiency
2011-001695-19Phase 4Completed
- Sponsor
- CSL Vifor
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic heart failure (CHF) and iron deficiency anemia (IDA) comparing Ferric carboxymaltose with Placebo (2 arms). Primary endpoint: Change in 6-minute walk test distance. Started Sep 2011; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
chronic heart failure (CHF)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2011-001695-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001695-19.